Stopping GLP-1 therapy doubles heart attack risk in type 2 diabetics
Published 1 d ago1 sourceEvidence: Reported
Dentists report an increase in patients experiencing oral side effects, termed 'Ozempic teeth', associated with GLP-1 drug use for diabetes and obesity. The condition is emerging as a secondary health consequence of the drugs' growing popularity, though the causal mechanism and prevalence remain unclear. This highlights a potential new public health consideration for the expanding GLP-1 patient population.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago1 sourceEvidence: Reported
Published 8 h ago1 sourceEvidence: Reported
Published 11 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 20 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported